|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 7/04 | |
| A61K 35/76 | |||
| C12N 15/863 | |||
| A61K 35/74 | |||
| C12Q 1/02 |
| (11) | Number of the document | 2028270 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08019998.7 |
| Date of filing the European patent application | 2004-06-18 | |
| (97) | Date of publication of the European application | 2009-02-25 |
| (45) | Date of publication and mention of the grant of the patent | 2012-02-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 03013826 | 2003-06-18 | EP | |
| 03018478 | 2003-08-14 | EP | |
| 03024283 | 2003-10-22 | EP |
| (72) |
Szalay, Aladar, US
Timiryasova, Tatyana, US
Yu, Yong A., US
Zhang, Qian, US
|
| (73) |
Genelux Corporation,
3030 Bunker Hill Street Suite 310, San Diego, California 92109,
US
|
| (54) | Modified recombinant vaccinia viruses, uses thereof |
| Modified recombinant vaccinia viruses, uses thereof |